22nd week of 2022 patent applcation highlights part 22 |
Patent application number | Title | Published |
20220169647 | TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS | 2022-06-02 |
20220169648 | 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF | 2022-06-02 |
20220169649 | TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS | 2022-06-02 |
20220169650 | TRICYCLIC COMPOUNDS | 2022-06-02 |
20220169651 | TYK2 PSEUDOKINASE LIGANDS | 2022-06-02 |
20220169652 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | 2022-06-02 |
20220169653 | PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES | 2022-06-02 |
20220169654 | New Organic Compounds | 2022-06-02 |
20220169655 | 2-PHENYL-3,4-DIHYDROPYRROLO[2,1 -F] [1,2,4]TRIAZINONE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS AND USES THEREOF | 2022-06-02 |
20220169656 | NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | 2022-06-02 |
20220169657 | ORGANIC COMPOUND AND APPLICATION THEREOF | 2022-06-02 |
20220169658 | CRYSTAL FORM OF GONADOTROPIN RELEASING HORMONE ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | 2022-06-02 |
20220169659 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 2022-06-02 |
20220169660 | CYCLIC AMINO-PYRAZINECARBOXAMIDE COMPOUNDS AND USES THEREOF | 2022-06-02 |
20220169661 | IMIDAZO NITROGEN HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | 2022-06-02 |
20220169662 | A POLYMER COATED METAL-ORGANIC FRAMEWORK | 2022-06-02 |
20220169663 | Metal-Organic Framework Materials Comprising A Diimine Bis-Salicylate Scaffold And Methods For Production Thereof | 2022-06-02 |
20220169664 | MULTIFUNCTIONALIZED SILICON NANOPARTICLES, PROCESS FOR THEIR PREPARATION AND USES THEREOF IN ELECTROCHEMILUMINESCENCE BASED DETECTION METHODS | 2022-06-02 |
20220169665 | METHOD FOR PRODUCING NITROGEN-CONTAINING ORGANOXYSILANE COMPOUND | 2022-06-02 |
20220169666 | PYRIDINE SULFONAMIDE PHOSPHATE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 2022-06-02 |
20220169667 | PRODUCTION METHOD OF BIARYLPHOSPHINE | 2022-06-02 |
20220169668 | METHODS OF TREATING NEUROCOGNITIVE DISORDERS, CHRONIC PAIN AND REDUCING INFLAMMATION | 2022-06-02 |
20220169669 | HIGH-AFFINITY CU(I) LIGANDS AND METHODS OF USE THEREOF | 2022-06-02 |
20220169670 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2022-06-02 |
20220169671 | NUCLEIC ACID COMPOUND AND OLIGONUCLEOTIDE | 2022-06-02 |
20220169672 | COMPOUNDS FOR TARGETED THERAPIES OF CASTRATION RESISTANT PROSTATE CANCER | 2022-06-02 |
20220169673 | LIPIDIC ANALOGS OF ANTI-CANCER STEM CELL AGENT | 2022-06-02 |
20220169674 | A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID | 2022-06-02 |
20220169675 | Method for the reduction of host cell proteins in affinity chromatography | 2022-06-02 |
20220169676 | INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES | 2022-06-02 |
20220169677 | NRP-1 BINDING INHIBITORY PEPTIDES AND USES THEREOF | 2022-06-02 |
20220169678 | PEPTIDE HAVING ACTIVITIES OF SKIN WHITENING AND USES THEREOF | 2022-06-02 |
20220169679 | NOVEL ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES | 2022-06-02 |
20220169680 | CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN | 2022-06-02 |
20220169681 | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use | 2022-06-02 |
20220169682 | SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF | 2022-06-02 |
20220169683 | MSP NANOPORES AND USES THEREOF | 2022-06-02 |
20220169684 | CHANNELRHODOPSINS FOR OPTICAL CONTROL OF CELLS | 2022-06-02 |
20220169685 | TREATMENT OF ISCHEMIA | 2022-06-02 |
20220169686 | VARIANT OF A BPIFB4 PROTEIN | 2022-06-02 |
20220169687 | METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS | 2022-06-02 |
20220169688 | SELECTIVE TARGETING OF UBIQUITIN- AND UBIQUITIN-LIKE E1-ACTIVATING ENZYMES BY STRUCTURALLY-STABILIZED PEPTIDES | 2022-06-02 |
20220169689 | STAT3 TRANSCRIPTOME FOR DESIGNING MORE POTENT NK CELLS | 2022-06-02 |
20220169690 | RECOMBINANT MILK PROTEINS AND FOOD COMPOSITIONS COMPRISING THE SAME | 2022-06-02 |
20220169691 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2022-06-02 |
20220169692 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | 2022-06-02 |
20220169693 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | 2022-06-02 |
20220169694 | CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY | 2022-06-02 |
20220169695 | T CELL RECEPTORS AND METHODS OF USE THEREOF | 2022-06-02 |
20220169696 | T CELL RECEPTORS AND METHODS OF USE THEREOF | 2022-06-02 |
20220169697 | High-Affinity TCR for Recognizing AFP Antigen | 2022-06-02 |
20220169698 | Compositions and Methods for Treating Cancer with DuoCARs | 2022-06-02 |
20220169699 | PD-1-CD28 FUSION PROTEINS AND THEIR USE IN MEDICINE | 2022-06-02 |
20220169700 | GENE-EDITED NATURAL KILLER CELLS | 2022-06-02 |
20220169701 | Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer | 2022-06-02 |
20220169702 | TGF-B-RECEPTOR ECTODOMAIN FUSION MOLECULES AND USES THEREOF | 2022-06-02 |
20220169703 | NOVEL FUSION MOLECULES AND USES THEREOF | 2022-06-02 |
20220169704 | SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES | 2022-06-02 |
20220169705 | TOPICAL APPLICATION FOR AN ANTI-HSV ANTIBODY | 2022-06-02 |
20220169706 | ENGINEERED ANTIBODIES | 2022-06-02 |
20220169707 | ANTIBODIES TARGETING HIV ESCAPE MUTANTS | 2022-06-02 |
20220169708 | NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif) | 2022-06-02 |
20220169709 | GRP78 AND/OR HSP70 INHIBITORS FOR THERAPEUTIC USE | 2022-06-02 |
20220169710 | ANTIBODY FOR ENRICHMENT OF CELLS | 2022-06-02 |
20220169711 | Compositions, Devices, Kits and Methods for Detecting Hookworm | 2022-06-02 |
20220169712 | METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN | 2022-06-02 |
20220169713 | METHODS FOR TREATING OSTEOARTHRITIS PAIN BY ADMINISTERING A NERVE GROWTH FACTOR ANTAGONIST AND COMPOSITIONS CONTAINING THE SAME | 2022-06-02 |
20220169714 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES INVOLVING CXCL1 FUNCTION | 2022-06-02 |
20220169715 | METHODS FOR MODULATING INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE LUNG | 2022-06-02 |
20220169716 | PHARMACEUTICAL FORMULATIONS FOR ADALIMUMAB | 2022-06-02 |
20220169717 | IL-7 Binding Proteins and Their use in Medical Therapy | 2022-06-02 |
20220169718 | MONOCLONAL ANTI-IL-1RACP ANTIBODIES | 2022-06-02 |
20220169719 | IL-6 ANTIBODIES | 2022-06-02 |
20220169720 | THREONINE166 AND SERINE189 OF RUBICON RUN DOMAIN AS LRRK2 KINASE INHIBITION TARGET SITES | 2022-06-02 |
20220169721 | Compositions and Methods for Targeting Connexin Hemichannels | 2022-06-02 |
20220169722 | NOVEL ANTI-LAG-3 ANTIBODY POLYPEPTIDE | 2022-06-02 |
20220169723 | TAGGED CHIMERIC EFFECTOR MOLECULES AND RECEPTORS THEREOF | 2022-06-02 |
20220169724 | Inhibitory Immune Receptor Inhibition Methods and Compositions | 2022-06-02 |
20220169725 | BIO-RESPONSIVE ANTIBODY COMPLEXES FOR ENHANCED IMMUNOTHERAPY | 2022-06-02 |
20220169726 | ANTI-SIRPalpha MONOCLONAL ANTIBODIES AND USES THEREOF | 2022-06-02 |
20220169727 | ANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUCATES AND USES THEREOF | 2022-06-02 |
20220169728 | BISPECIFIC ANTIBODIES AND USES THEREOF | 2022-06-02 |
20220169729 | METHOD FOR THE GENERATION OF A TRIVALENT ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION | 2022-06-02 |
20220169730 | METHOD FOR THE GENERATION OF A BIVALENT, BISPECIFIC ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION | 2022-06-02 |
20220169731 | METHOD FOR THE GENERATION OF A MULTIVALENT, BISPECIFIC ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION | 2022-06-02 |
20220169732 | SMALL SHEDDING BLOCKING AGENTS | 2022-06-02 |
20220169733 | Immunological Reagents | 2022-06-02 |
20220169734 | ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3) | 2022-06-02 |
20220169735 | METHODS OF SENSITIZING CANCER TO IMMUNOTHERAPY | 2022-06-02 |
20220169736 | COMBINATIONS OF ANTI-ILDR2 ANTIBODIES AND PD-1 ANTAGONISTS | 2022-06-02 |
20220169737 | METHODS OF DEPLETING DISEASE CAUSING AGENTS VIA ANTIBODY TARGETED PHAGOCYTOSIS | 2022-06-02 |
20220169738 | MONOCLONAL ANTIBODIES AGAINST HER2 | 2022-06-02 |
20220169739 | METHODS FOR TREATING ASTHMA IN PEDIATRIC SUBJECTS BY ADMINISTERING AN IL-4R ANTAGONIST | 2022-06-02 |
20220169740 | NGF Antagonists for Medical Use | 2022-06-02 |
20220169741 | Methods of Engineering Surface Charge for Bispecific Antibody Production | 2022-06-02 |
20220169742 | ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF | 2022-06-02 |
20220169743 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | 2022-06-02 |
20220169744 | ANTI-JAGGED1 ANTIGEN BINDING PROTEINS | 2022-06-02 |
20220169745 | ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1 | 2022-06-02 |
20220169746 | ANTIBODIES TO NEOANTIGENS AND USES THEREOF | 2022-06-02 |